AR073810A1 - Polipeptidos que tienen actividad antimicrobiana - Google Patents
Polipeptidos que tienen actividad antimicrobianaInfo
- Publication number
- AR073810A1 AR073810A1 ARP090103898A ARP090103898A AR073810A1 AR 073810 A1 AR073810 A1 AR 073810A1 AR P090103898 A ARP090103898 A AR P090103898A AR P090103898 A ARP090103898 A AR P090103898A AR 073810 A1 AR073810 A1 AR 073810A1
- Authority
- AR
- Argentina
- Prior art keywords
- xaa
- gly
- cys
- lys
- polypeptide
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 230000000845 anti-microbial effect Effects 0.000 title abstract 5
- 230000000813 microbial effect Effects 0.000 abstract 4
- 239000004599 antimicrobial Substances 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000009261 transgenic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Método para producir el polipéptido, una planta transgénica, una composicion farmacéutica que comprende un polipéptido antimicrobiano tal como el definido. Reivindicacion 1: Un polipéptido que tiene actividad antimicrobiana, seleccionado del grupo que consiste en: (a) un polipéptido que comprende la secuencia de amino ácido de SEC ID NO:1: Gly-Phe-Gly-Cys-Asn-Gly-Pro-Trp-Ser-Glu-Asp-Asp-Leu-Xaa-Cys-His-Xaa-His-Cys-Lys-Ser-Ile-Lys-Gly -Tyr-Xaa-Gly-Gly-Tyr-Cys-Ala-Lys-Gly-Gly-Phe-Xaa-Cys-Lys-Cys-Tyr; donde Xaa en la posicion 14 es Arg o Lys; Xaa en la posicion 17 es Asn o Arg; Xaa en la posicion 26 es Arg o Lys; Xaa en la posicion 36 es Val o Leu; y (b) un fragmento (a) que tiene actividad antimicrobiana. Reivindicacion 16: Un método para matar o inhibir el crecimiento de células microbianas que comprende poner en contacto las células microbianas con un polipéptido antimicrobiano tal como se definio en cualquiera de las reivindicaciones 1-5. Reivindicacion 17: Un método para el tratamiento de una infeccion microbiana que comprende administrar a un ser humano o a un animal un polipéptido de cualquiera de las reivindicaciones 1-5 en una cantidad eficaz para tratar la infeccion microbiana.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08166409 | 2008-10-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR073810A1 true AR073810A1 (es) | 2010-12-01 |
Family
ID=41381803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090103898A AR073810A1 (es) | 2008-10-10 | 2009-10-09 | Polipeptidos que tienen actividad antimicrobiana |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20100093633A1 (es) |
| EP (1) | EP2337792A1 (es) |
| CN (1) | CN102245630A (es) |
| AR (1) | AR073810A1 (es) |
| PA (1) | PA8845301A1 (es) |
| TW (1) | TW201018401A (es) |
| UY (1) | UY32171A (es) |
| WO (1) | WO2010040845A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE368105T1 (de) * | 2003-02-07 | 2007-08-15 | Novozymes As | Proteasen |
| EP1673451B1 (en) * | 2003-10-10 | 2010-12-15 | Novozymes A/S | Protease variants |
| ES2380105T3 (es) | 2004-06-21 | 2012-05-08 | Novozymes A/S | Proteasas de Nocardiopsis |
| BRPI0609801B1 (pt) * | 2005-06-06 | 2018-05-29 | Novozymes Adenium Biotech A/S | Polipeptídeo, polinucleotídeo, construção de ácido nucleico, vetor de expressão recombinante,microrganismo recombinante, método para produção do polipeptídeo, composição antimibrobiana, método in vitro para matar ou inibir o crescimento 5 de células microbianas, e, uso de um polipeptídeo antimicrobiano |
| CN104945467B (zh) * | 2015-06-23 | 2018-12-18 | 中山大学 | 一种抗菌肽的人工合成方法 |
| CN110272474B (zh) * | 2019-05-15 | 2021-06-01 | 中国农业大学 | 大麦虫天然抗菌蛋白及其制备方法与应用 |
| CN116262781B (zh) * | 2021-12-13 | 2024-05-14 | 中国农业大学 | 抗菌肽defensin衍生物及其原核表达方法与应用 |
| CN116196393A (zh) * | 2022-12-23 | 2023-06-02 | 中国农业科学院饲料研究所 | 抗菌肽ap138在制备抗菌药物中的应用 |
| CN118516389B (zh) * | 2024-07-19 | 2024-10-29 | 中国农业大学三亚研究院 | Zophobas atratus防御素高效信号肽筛选菌株的制备方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4361796B2 (ja) * | 2001-11-20 | 2009-11-11 | ノボザイムス アクティーゼルスカブ | シュードプレクタニア・ニグレラからの抗菌ポリペプチド |
| BRPI0609801B1 (pt) * | 2005-06-06 | 2018-05-29 | Novozymes Adenium Biotech A/S | Polipeptídeo, polinucleotídeo, construção de ácido nucleico, vetor de expressão recombinante,microrganismo recombinante, método para produção do polipeptídeo, composição antimibrobiana, método in vitro para matar ou inibir o crescimento 5 de células microbianas, e, uso de um polipeptídeo antimicrobiano |
| RU2010140886A (ru) * | 2008-03-07 | 2012-04-20 | Новозимс Эдениум Байотек А/С (Dk) | Применение дефенсинов при туберкулезе |
-
2009
- 2009-10-08 US US12/575,535 patent/US20100093633A1/en not_active Abandoned
- 2009-10-09 WO PCT/EP2009/063220 patent/WO2010040845A1/en not_active Ceased
- 2009-10-09 CN CN2009801494985A patent/CN102245630A/zh active Pending
- 2009-10-09 TW TW098134228A patent/TW201018401A/zh unknown
- 2009-10-09 UY UY0001032171A patent/UY32171A/es unknown
- 2009-10-09 EP EP09736901A patent/EP2337792A1/en not_active Withdrawn
- 2009-10-09 PA PA20098845301A patent/PA8845301A1/es unknown
- 2009-10-09 AR ARP090103898A patent/AR073810A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PA8845301A1 (es) | 2010-05-26 |
| CN102245630A (zh) | 2011-11-16 |
| EP2337792A1 (en) | 2011-06-29 |
| TW201018401A (en) | 2010-05-16 |
| US20100093633A1 (en) | 2010-04-15 |
| WO2010040845A1 (en) | 2010-04-15 |
| UY32171A (es) | 2010-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR073810A1 (es) | Polipeptidos que tienen actividad antimicrobiana | |
| ES2682670T3 (es) | Lisinas de bacteriófagos de Streptococcus para la detección y tratamiento de bacterias gram positivas | |
| RU2013126581A (ru) | Мутанты стрептокиназы и их ковалентно модифицированные формы | |
| MX347600B (es) | Uso de una composicion que comprende un peptido antimicrobiano como un conservador de alimentos. | |
| MX2011000047A (es) | Uso de factores de crecimiento recombinantes derivados de plantas en el cuidado de la piel. | |
| AR065289A1 (es) | Antagonistas de activina - actriia y sus usos para la promocion del crecimiento oseo y el tratamiento de mieloma multiple | |
| AR073237A1 (es) | Proteinas de bacillus thuringiensis que son toxinas activas contra hemipteros y coleopteros | |
| MX348464B (es) | Agente inductor de inmunidad. | |
| EP4349360A3 (en) | Peptide exhibiting wrinkle-improving activity and uses thereof | |
| RU2010140886A (ru) | Применение дефенсинов при туберкулезе | |
| EA201290130A1 (ru) | Комбинации биологически активных соединений | |
| PE20170942A1 (es) | Proteinas de variantes de secuencias de aminoacidos de cry1da1 activas para lepidopteros | |
| RU2017116973A (ru) | Способы применения и композиции нейрегулинов для предотвращения, лечения или замедления сердечной недостаточности с сохраненной фракцией выброса | |
| CU24746B1 (es) | Apirasas humanas, solubilizadas y modificadas útiles para prevenir y tratar el daño tisular | |
| CO6020015A1 (es) | Tratamiento de cultivos horticolas | |
| SG10201406288SA (en) | Multimeric forms of antimicrobial peptides | |
| CY1120003T1 (el) | Αντιμικροβιακη πρωτεϊνη | |
| NZ610620A (en) | Inhibitors of apoptosis and uses thereof | |
| WO2018155813A3 (ko) | 엔테로코쿠스 패슘에 대하여 용균력을 가지는 신규한 항균단백질 efal-2 | |
| AR095076A1 (es) | Péptidos y composiciones para el tratamiento de daño articular | |
| JP2013539776A5 (es) | ||
| EA202091496A1 (ru) | Вариант инсектицидного гена axmi115 и способы его применения | |
| AR087719A2 (es) | Celula de planta transformada, cultivo de tejidos y planta transgenica | |
| NZ565242A (en) | Protein extracted from plants of the genus lupinus or produced in recombinant form, nucleotide sequence encoding it and its use in animal nutrition, as a plant growth promoter and in the fight against pathogenic fungi | |
| MX2018008545A (es) | Composicion antibacteriana y metodo para tratar infecciones por estafilococos con la composicion antibacteriana. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |